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The following information was missing from the legend for Figure 1: closed squares, NVP; open squares, EFV; error bars 
denote standard errors. Oliver Flint at Bristol-Myers Squibb alerted PLoS Medicine to this omission. 
There was also a line with open circles in Figure 1F that should not have been included.
This correction note may be found online at DOI: 10.1371/journal.pbio.0010073.
DOI: 10.1371/journal.pmed.0010073.g001
Figure 1. Change in Plasma Concentrations of Lipids and Lipoproteins
Adjusted for sex, region, pVL decrease, and CD4+-cell increase. 
Closed squares, NVP; open squares, EFV; error bars denote standard 
errors.
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